High-purity recombinant human-like fibronectin retaining dense RGD cell-adhesion motifs. Directs keratinocyte spread and adhesion to accelerate self-repair of delicate barriers and reinforce the basement membrane.
Molecular Docking
AlphaDrugs computational biology molecular docking: Recombinant fibronectin & integrin binding.
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramAlphaDrugs AI platform: Fibronectin & Integrin molecular docking simulation model.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
Aqua, Glycerin、氯化钠、1,2-1,2-Hexanediol、Fibronectin、柠檬酸钠 |
INCI Name (EN) |
Aqua, Glycerin, Sodium Chloride, 1,2-Hexanediol, Fibronectin, Sodium Citrate |
| CAS No. |
7732-18-5 / 56-81-5 / 7647-14-5 / 6920-22-5 / 86088-83-7 / 68-04-2 |
Recommended Dosage |
1.0% - 5.0% (Recommended 2.0% - 3.0%) |
| Optimal pH Range |
6.0 - 7.2 |
Thermal Processing |
Add below 40°C during final gentle stirring step |
| Appearance & Odor |
Clear colorless liquid, odorless |
Solubility & Method |
Water soluble |
💡 Compatibility Guidelines & Precautions: Compatible with hyaluronic acid, glycerin, and non-ionic emulsifiers
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 101202-00075-7478 |
Supply Packaging |
1kg/fluorinated bottle, 5kg/drum, 25kg/drum |
| Minimum Order Quantity (MOQ) |
1 kg (Ready Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store refrigerated at 2-8°C, sealed and dark |
Shelf Life (Shelf Life) |
24 Months |
| R&D Sample Support |
Complimentary 30g trial sample available with application guidelines |
Quality Documentation |
Batch COA, SDS, TDS, Recombinant Purity Certificate |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Provides essential anchoring points for cell migration through RGD motifs, activating intracellular survival kinases to accelerate re-epithelialization and thicken fragile compromised barriers.
✨ Key Selling Point Keywords:
🏷️ Biomimetic Adhesion Support🏷️ Compromised Epidermal Barrier Repair🏷️ Fortifying Fragile Stratum Corneum🏷️ Relieving Facial Redness & Dry Itch🏷️ Firming & Elastic Fullness
🧴 Recommended Product Formats & Categories:
Barrier rescue essences, intensive recovery creams, post-laser soothing gels, high-potency soothing ampoules
📜 Patented Technologies & Scientific Backing:
Invention Patent on Industrialized Recombinant Fibronectin Biosynthesis
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
